In Aotearoa New Zealand, low-risk drinking advice is currently under review, although concerns have been raised about alcohol industry influence in this process, and the challenges of revising alcohol policy. Any review of low-risk drinking advice must be assessed not only against current scientific evidence, but also against Te Tiriti o Waitangi obligations to protect Māori health, reduce inequities and enable Māori participation and decision making in alcohol policy.
Full article available to subscribers
Alcohol is a leading contributor to preventable morbidity and mortality globally. Its health impacts are significant and continue to rise in many countries. According to the World Health Organization’s 2024 report, alcohol use was considered responsible for 2.6 million deaths, around 5% of all global deaths. Men account for three-quarters of those fatalities.1 Alcohol contributes to a range of health problems, including cancer, cardiovascular disease, injuries from road crashes, mental health disorders and infectious diseases.1 Alcohol-related harm also imposes substantial economic costs, underscoring the broader societal impact of alcohol use.
Governments have developed low-risk drinking advice to communicate epidemiological evidence about alcohol-related risk by defining thresholds of consumption associated with lower levels of harm.2,3 This advice is intended to inform public understanding, clinical practice and policy discussions. However, its effectiveness in improving population health outcomes is shaped by the wider regulatory and social environments in which alcohol is produced, marketed and consumed. A range of social, economic, commercial and environmental factors influence alcohol consumption, including the availability and marketing of alcohol, social norms and the broader conditions of inequity.4,5 In Aotearoa New Zealand, low-risk drinking advice is currently under review, although concerns have been raised about alcohol industry influence in this process, and the challenges of revising alcohol policy.6 Any review of low-risk drinking advice must be assessed not only against current scientific evidence, but also against Te Tiriti o Waitangi obligations to protect Māori health, reduce inequities and enable Māori participation and decision making in alcohol policy.
Within this global context, alcohol continues to impose a heavy toll on Aotearoa New Zealand’s health, society and economy. Despite its normalised place in social life, the harm caused by alcohol use is profound and persistent. Alcohol has a significant impact on New Zealanders’ health. It remains one of the leading causes of preventable illness and early death, responsible for about 5% of all deaths and 5% of all healthy years of life lost.7,8 Alcohol contributes to a large proportion of injuries and physical and mental health conditions, with nearly 4% of alcohol-related deaths caused by breast, colorectal and liver cancers.9–11 While alcohol-related death rates from some chronic conditions are lower than Organisation for Economic Co-operation and Development (OECD) averages (7.4 vs 8.5 per 100,000 for cancer and 1.9 vs 7.2 per 100,000 for liver disease),12 alcohol causes a substantial proportion of acute harms, including road trauma, suicide and drowning, accounting for approximately one-third of fatal crashes and suicides.13–15 Alcohol-related road traffic deaths are significantly higher in Aotearoa New Zealand than in other OECD countries, at 5.1 per 100,000, nearly double the OECD average of 2.8.12 In 2018, alcohol was linked to 901 deaths, 1,250 cancers, 29,282 hospitalisations and almost 50,000 Disability-Adjusted Life Years (DALYs) lost.16
Alcohol-related harm extends beyond the individual drinker, with significant harms experienced by others in Aotearoa New Zealand. Casswell et al. estimated that more than 78,000 healthy life years were lost in 2018 as a direct result of other people’s drinking, including harms from road injuries, child maltreatment and interpersonal violence.17 A substantial proportion of this burden is driven by foetal alcohol spectrum disorder (FASD), which results from prenatal alcohol exposure and causes lifelong disability. The total cost of FASD in Aotearoa New Zealand has been estimated at NZ$4.8 billion, reflecting both healthcare expenses and long-term social and economic losses.18 Around one-third of people who are pregnant in Aotearoa New Zealand report consuming alcohol, with about 12% engaging in binge drinking and 13% continuing beyond the first trimester.19–21 Alcohol use during pregnancy is shaped by a range of contextual factors, including intimate partner violence, poverty, stress, trauma, abuse, discrimination and partner drinking patterns.22,23 These conditions constrain individual agency and highlight the limitations of approaches that rely solely on information or advice to reduce harm. Alcohol-related violence, sexual assault and road crashes add billions more in annual costs, destabilising families and communities.18,24 These harms disproportionately affect whānau and communities already experiencing disadvantage, deepening existing inequities and perpetuating cycles of harm across generations. This pattern highlights that alcohol-related risk extends beyond the drinker and has implications for how low-risk drinking advice is conceptualised, developed and communicated. Collectively, these findings show that alcohol-related harm in Aotearoa New Zealand is a major public health issue produced through structural and relational conditions.
In addition to these broader effects, alcohol has a significant impact on Aotearoa New Zealand’s economy. The New Zealand Institute of Economic Research (2024) estimated that alcohol costs the country around NZ$9.1 billion annually, equivalent to nearly one-third of the national health budget.18 This total includes healthcare and treatment for alcohol use disorders as well as broader economic impacts from lost productivity, premature death and incarceration. The Government also spent an additional NZ$810 million directly through hospitalisations, emergency services and Accident Compensation Corporation compensation, highlighting the substantial direct fiscal burden on the government and the importance of alcohol policy in shaping health system costs. Together, these figures demonstrate that alcohol-related harm is not confined to individuals but reflects wider social and economic systems that generate substantial collective costs.
Alcohol-related harm in Aotearoa New Zealand is not experienced equally. Māori, Pacific people and people living in socio-economically deprived areas face much higher rates of alcohol-related disease, injury and early death than other groups.7,16 These inequities are produced through structural and commercial factors, such as the higher density of alcohol outlets in disadvantaged areas, targeted marketing and limited access to culturally safe health and addiction services.16,25 These environments are actively shaped by the alcohol industry through marketing practices, pricing strategies and influence over regulatory settings. For example, off-licence alcohol outlet density is almost three times higher in high-deprivation communities (94.6 per 100,000 people) than in low-deprivation areas (31.0 per 100,000).16,25 Communities with a higher proportion of Māori also face greater exposure, with 74.5 outlets per 100,000 people compared with 56.4 per 100,000 in areas with fewer Māori.16,25 These patterns reflect a well-established alcohol harm paradox, whereby groups experiencing greater socio-economic disadvantage experience disproportionately high levels of harm despite similar or lower levels of consumption.1 In Aotearoa New Zealand, these inequities are further intensified by colonial and contemporary policy arrangements that have concentrated harmful alcohol environments in already disadvantaged communities and limited Māori access to self-determined, culturally safe forms of prevention and care.16,26 Under Te Tiriti o Waitangi, the Crown has a responsibility to protect Māori health and address inequities in alcohol-related harm disparities, and enable Māori self-determination in alcohol policy. Addressing these inequities requires structural policy responses, including stronger regulation of alcohol availability and marketing, greater investment in prevention and treatment, and Māori and Pacific leadership and decision-making authority to ensure policies promote health equity.27
Government low-risk drinking advice provides thresholds derived from epidemiological evidence to indicate levels of consumption associated with lower risk of harm.1 Such advice translates complex epidemiological evidence into accessible public health information and is intended to support informed decision making, clinical practice and policy development.28–31 By defining recommended daily, weekly and single-occasion (binge) limits, low-risk drinking advice specifies levels of consumption associated with lower probabilities of acute alcohol-related harms (e.g., accidents, injuries and violence) and chronic conditions (e.g., cancers, liver disease and cardiovascular illnesses). This is especially important given that while some alcohol use is labelled “low risk” or “safe” for consumption, current evidence shows that no level of alcohol use is completely risk free.32
Beyond informing individual behaviour, low-risk drinking advice also informs national health policies. It contributes to the evidentiary and normative basis for population-level measures, such as taxation, licensing rules and labelling requirements. These regulatory interventions themselves, rather than advice, are the primary drivers of reductions in alcohol-related harm.33 Low-risk drinking advice also helps health professionals to identify at-risk drinkers through screening, provide opportunistic advice in the form of a brief intervention and link individuals to support before serious harm occurs. Collectively, these functions position low-risk drinking advice as one component within a broader system of alcohol control, rather than a standalone intervention. However, to remain effective, low-risk drinking advice must be kept up to date as scientific understanding evolves.34,35 Earlier advice was developed when evidence on long-term health outcomes, particularly at low levels of consumption, was more limited. Current evidence demonstrates that even small amounts of alcohol can increase the risk of disease, meaning outdated thresholds may underestimate harm and contribute to the normalisation of higher-risk consumption patterns.32
Over the past decade, research has shown that alcohol increases the risk of multiple cancers, heart disease and injury, and that any potential health benefits once linked to moderate drinking are minimal or non-existent.1,32 This evidence has led to a shift in how alcohol-related risk is conceptualised and communicated, moving away from categorical notions of “safe” drinking towards a continuum of risk. As a result, several high-income countries have revisited their national low-risk drinking advice.29–31
In 2016, the United Kingdom (UK) completed its review and replaced low-risk drinking advice previously established in 1995.29 The 2-year review process drew on expert national and international evidence, including mathematical models of population drinking and mortality data, which estimated 14 units per week as the upper limit of low risk, equivalent to about a 1% lifetime risk of death from alcohol-related causes. The low-risk drinking advice determined by the UK expert working group was that adults who choose to drink should consume no more than 14 units of alcohol per week (with one standard drink defined as 8g of pure alcohol), spread evenly over several days with alcohol-free days each week. In 2020, Australia also published a comprehensive review to update its 2009 national alcohol advice.30 Using a similar methodology to the UK, the review defined thresholds below which the lifetime risk of alcohol-attributable death remains less than one in 100. The revised advice recommends that adults consume no more than 10 standard drinks per week (one standard drink equalling 10g of pure alcohol), with the same limits applying to men and women. Following these updates, the Canadian Centre on Substance Use and Addiction was commissioned by the Canadian Government to review the national alcohol guidance, following which it released updated recommendations for the Canadian public in 2023.31 Although these have not yet replaced the official government advice, the review used similar approaches, including modelling consumption and mortality. The findings indicated that consuming more than two standard drinks per week (with one standard drink defined as 13.45g of pure alcohol) exceeded a one-in-1,000 lifetime risk threshold for alcohol-related death, while more than six standard drinks per week exceeded the one-in-100 threshold. The expert group therefore recommended classifying up to two standard drinks per week as low risk, three to six drinks as moderate risk and more than six drinks as increasingly high risk.
Across these reviews, several conclusions are evident: no level of alcohol use is completely risk free; risk increases in a dose–response relationship with consumption (i.e., the more you drink, the worse the harm); and advice has shifted towards lower risk thresholds and gender-neutral recommendations. Abstinence is identified as the lowest-risk option, essential for those who are pregnant. Together, these revisions reflect a broader shift towards more precautionary and transparent approaches to communicating alcohol-related risk.
Aotearoa New Zealand’s current low-risk drinking advice, last updated in 2011, was developed in a different scientific context36 when evidence linking alcohol use to chronic disease, particularly at low levels of consumption, was less developed. Since then, considerable evidence has led to a growing consensus that no amount of alcohol can be considered completely safe.32 Research has strengthened the understanding of alcohol’s contribution to a wide range of harms, including several types of cancers and cardiovascular disease.37,38 Aotearoa New Zealand’s current guidance is therefore misaligned with current scientific evidence and with advice in other comparable countries. This misalignment has implications for how alcohol-related risk is communicated and understood at the population level.
The amount of alcohol that people drink contributes to risk levels. In an international context, Aotearoa New Zealand has relatively high levels of alcohol consumption, reflecting the normalisation of alcohol use within social life. According to World Health Organization data, New Zealanders consumed about 9.3 litres of pure alcohol per person per year, compared with an OECD average of 8.3 litres.12 Around 80% of Aotearoa New Zealand adults reported drinking alcohol, compared with about 70% across the OECD. Approximately 41% of adults in Aotearoa New Zealand reported heavy episodic drinking (defined as consuming six or more standard alcoholic drinks on one occasion, with one standard drink containing 10g of pure alcohol) in the past month, compared with 33% across the OECD, placing Aotearoa New Zealand among the top five OECD countries. Among drinkers, this figure rises to 47.6%, which is also higher than the OECD average (40.6%).12 Similar patterns appear among young people aged 15–19 years, with 64% of younger New Zealanders reporting current drinking and more than one-third reporting binge drinking in the past month, figures that are both higher than OECD averages.12 These patterns indicate that alcohol use is normalised through social, commercial and policy environments in Aotearoa New Zealand. Current low-risk drinking advice in Aotearoa New Zealand recommends weekly limits of 15 standard drinks for men (no more than three per day) and 10 for women (no more than two per day), with at least two alcohol-free days each week.36 In this context, the effectiveness of guideline-based approaches is constrained by commercial environments in which alcohol is actively promoted and normalised. In recent years, this has been further intensified by the growth of social media and algorithmically targeted digital marketing, which increases exposure and engagement with alcohol promotion, particularly among young people and other population groups.39–41 Guideline-based approaches, therefore, need to be accompanied by broader policy measures that address availability, marketing and social norms.
Low-risk drinking advice in Aotearoa New Zealand needs urgent review. The current advice, last updated in 2011, is outdated, developed before research demonstrated that even small amounts of alcohol can increase the risk of cancer, heart disease and other chronic health conditions. Updating national advice using evidence-informed review processes like those used in comparable countries is necessary to ensure that risk is communicated accurately.
We recommend that the first step should be a comprehensive review of the 2011 low-risk drinking advice. This review needs to draw on the latest national and international evidence about alcohol’s health, social and economic impacts, as well as how harm is distributed across the population. The review should be situated within an understanding of the wider structural conditions that shape alcohol use, including alcohol availability (such as outlet density), marketing exposure, socio-economic inequities and access to culturally safe support.
We also recommend, following examples set by other jurisdictions, that Aotearoa New Zealand should develop population-specific modelling to estimate how drinking affects health outcomes. Such modelling would quantify both short-term risks (such as injury) and long-term risks (such as cancer and heart disease) and help identify thresholds that better reflect local drinking patterns and health priorities.
We recommend that the advice review process prioritise those most affected by harm and be carried out in genuine partnership with Māori and Pacific communities, consistent with Te Tiriti o Waitangi. This includes ensuring substantive Māori and Pacific leadership in decision making, drawing on mātauranga Māori and Pacific knowledges and supporting community-led approaches to prevention, education and treatment. Reducing inequities in alcohol-related harm must be central to this review process, and advice may produce or exacerbate inequities if it is based primarily on population averages rather than the distribution of harm, which currently most severely impacts Māori, Pacific people and people living in low socio-economic areas.
We further recommend the establishment of a multidisciplinary national expert panel to guide the review, one that includes Māori and Pacific health experts, addiction specialists, public health clinicians and researchers and communication professionals, and explicitly excludes representatives of the alcohol industry. This stated expertise and the exclusion of industry influence will maintain the independence and credibility of the panel, thus aligning it with panels utilised in reviews in other jurisdictions. The panel’s role would be to assess the evidence, develop recommendations and ensure that guidance is transparent and contextually appropriate.
We strongly recommend that the review process include public consultation. A staged approach, similar to that used in Canada, would involve presenting evidence and rationale for revision, followed by consultation on draft recommendations. Such processes can strengthen transparency, public accountability and legitimacy.
Finally, we recommend that careful attention be given to the implementation of revised advice. Implementation science can be used to assess how messages are understood across different communities and to monitor their effects over time. Continuous review will ensure the advice remains useful and up to date as new evidence emerges.
Updating Aotearoa New Zealand’s low-risk drinking advice is more than a technical exercise; it is an opportunity to improve how alcohol-related risk is defined and communicated. Aligning national advice with current scientific evidence and international practice would strengthen its credibility and relevance. To maintain integrity, the review process must be independent of the alcohol industry’s influence. Importantly, alcohol-related harm is produced through structural and commercial conditions that shape patterns of consumption and distribute risk unevenly across the population. Therefore, to be effective, low-risk drinking advice updates must be undertaken as part of a broader public health strategy that addresses the commercial and structural production of alcohol-related harm, centres equity and upholds Te Tiriti o Waitangi. Without such an approach, revised advice may improve the accuracy of official risk communication while leaving the underlying distribution of harm largely unchanged.
Alcohol remains a major contributor to preventable morbidity and mortality in Aotearoa New Zealand, generating substantial health, social and economic harm. Current low-risk drinking advice, last updated in 2011, no longer reflects contemporary evidence on alcohol-related risk. Internationally, several countries have revised their guidance in response to strengthened evidence that even low levels of consumption increase the risk of disease. This viewpoint argues that Aotearoa New Zealand’s low-risk drinking advice is now overdue for review. Updating national guidance is necessary to ensure that alcohol-related risk is communicated accurately and transparently and to provide a clearer foundation for clinical practice and policy. However, on its own, such advice cannot reduce alcohol-related harm, as information alone cannot address the structural conditions that produce it. The impact of evidence-based advice depends on the broader regulatory, commercial and social environments in which alcohol is produced, marketed and consumed. A review process must therefore be embedded within a wider strategy that addresses structural drivers of harm and prioritises equity, including obligations under Te Tiriti o Waitangi.
Dr Tasnima Akter: Faculty of Medical and Health Sciences, The University of Auckland, Aotearoa New Zealand.
Associate Professor David Newcombe: School of Health, University of the Sunshine Coast, Australia; Centre for Addiction Research, Faculty of Medical and Health Sciences, The University of Auckland, Aotearoa New Zealand.
Associate Professor Andy Towers: School of Health Sciences, Massey University, Aotearoa New Zealand.
Mr Mark Esekielu: Le Va, Aotearoa New Zealand.
Professor Christina Severinsen: School of Health Sciences, Massey University, Aotearoa New Zealand.
Dr Felicity Ware: Hāpai Te Hauora, Aotearoa New Zealand.
Professor Antonia Lyons: Centre for Addiction Research, Faculty of Medical and Health Sciences, The University of Auckland, Aotearoa New Zealand.
This project was funded by Health New Zealand – Te Whatu Ora as a component of a contracted research project reviewing the evidence underpinning the Aotearoa New Zealand national low-risk drinking advice.
Dr Tasnima Akter: Faculty of Medical and Health Sciences, The University of Auckland, Aotearoa New Zealand.
FW reports support for this manuscript through a subcontract from Massey University to undertake a Māori review of the evidence collated to inform potential health guidelines for alcohol, with payments made to Hāpai Te Hauora, a Māori public health organisation.
AL reports support for this manuscript through the philanthropic-funded Chair in Addiction Research from the Hugh Green Foundation via The University of Auckland.
1) World Health Organization. Global status report on alcohol and health and treatment of substance use disorders [Internet]. Geneva: World Health Organization; 2024 [cited 2025 Oct 30]. Available from: https://www.who.int/publications/i/item/9789240096745
2) Shield K, Paradis C, Butt P, et al. New perspectives on how to formulate alcohol drinking guidelines. Addiction. 2024;119(1):9-19. doi: 10.1111/add.16316.
3) Paula CST, Chagas C, Martins LB, Ferri CP. Low-risk Drinking Guidelines Around the World: An Overview of the Current Situation. Addict Disord Their Treat. 2020;19(4):218-227. doi: 10.1097/ADT.0000000000000225.
4) Khamis AA, Salleh SZ, Ab Karim MS, et al. Alcohol Consumption Patterns: A Systematic Review of Demographic and Sociocultural Influencing Factors. Int J Environ Res Public Health. 2022;19(13):8103. doi: 10.3390/ijerph19138103.
5) Finan LJ, Lipperman-Kreda S, Grube JW, et al. Alcohol Marketing and Adolescent and Young Adult Alcohol Use Behaviors: A Systematic Review of Cross-Sectional Studies. J Stud Alcohol Drugs Suppl. 2020(19):42-56. doi: 10.15288/jsads.2020.s19.42.
6) Towers A, Severinsen C, Lyons A, et al. Reconsidering our low-risk alcohol advice: The dark influence of the alcohol industry [Internet]. New Zealand: Public Health Communication Centre Aotearoa; 2025 [cited 2026 May 4]. Available from: https://www.phcc.org.nz/briefing/reconsidering-our-low-risk-alcohol-advice-dark-influence-alcohol-industry
7) Connor J, Kydd R, Shield K, Rehm J. The burden of disease and injury attributable to alcohol in New Zealanders under 80 years of age: marked disparities by ethnicity and sex. N Z Med J. 2015;128(1409):15-28.
8) Ministry of Health – Manatū Hauora. Longer, Healthier Lives: New Zealand’s Health 1990-2017 [Internet]. Wellington, New Zealand: Ministry of Health – Manatū Hauora; 2020 [cited 2025 Oct 28]. Available from: https://www.health.govt.nz/system/files/2020-02/longer-healthier-lives-new-zealands-health-1990-2017.pdf
9) Connor J, Kydd R, Maclennan B, et al. Alcohol‐attributable cancer deaths under 80 years of age in New Zealand. Drug Alcohol Rev. 2017;36(3):415-423. doi: 10.1111/dar.12443.
10) Hayes J, Richardson A, Frampton C. Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women. Intern Med J. 2013;43(11):1198-1204. doi: 10.1111/imj.12256.
11) Richardson A, Hayes J, Frampton C, Potter J. Modifiable lifestyle factors that could reduce the incidence of colorectal cancer in New Zealand. N Z Med J. 2016;129(1447):13-20.
12) World Health Organization. Global Information System on Alcohol and Health [Internet]. Geneva: World Health Organization; 2025 [cited 2025 Oct 27]. Available from: https://www.who.int/data/gho/data/themes/global-information-system-on-alcohol-and-health
13) Crossin R, Cleland L, Beautrais A, et al. Acute alcohol use and suicide deaths: an analysis of New Zealand coronial data from 2007-2020. N Z Med J. 2022;135(1558):65-78. doi: 10.26635/6965.5693.
14) Peden AE, Franklin RC, Clemens T. Exploring the burden of fatal drowning and data characteristics in three high income countries: Australia, Canada and New Zealand. BMC Public Health. 2019;19(1):794. doi: 10.1186/s12889-019-7152-z.
15) Poulsen H, Moar R, Pirie R. The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs. Accid Anal Prev. 2014;67:119-128. doi: 10.1016/j.aap.2014.02.019.
16) Chambers T, Mizdrak A, Jones AC, et al. Estimated alcohol-attributable health burden in Aotearoa New Zealand [Internet]. Wellington: University of Otago, University of Victoria, Canadian Institute for Substance Use Research, Health New Zealand – Te Whatu Ora; 2024 [cited 2025 Oct 28]. Available from: https://ourarchive.otago.ac.nz/esploro/outputs/report/Estimated-alcohol-attributable-health-burden-in-Aotearoa/9926583630901891/filesAndLinks?index=0
17) Casswell S, Huckle T, Romeo JS, et al. Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data. Addiction. 2024;119(5):855-862. doi: 10.1111/add.16435.
18) New Zealand Institute of Economic Research. Costs of alcohol harms in New Zealand: Updating the evidence with recent research [Internet]. Wellington: Ministry of Health – Manatū Hauora; 2024 [cited 2025 Oct 28]. Available from: https://www.health.govt.nz/system/files/2024-06/costs-of-alcohol-harms-in-new-zealand-2may24-v2.pdf
19) MacFarlane ME, Thompson JMD, Wilson J, et al. Infant Sleep Hazards and the Risk of Sudden Unexpected Death in Infancy. J Pediatr. 2022;245:56-64. doi: 10.1016/j.jpeds.2022.01.044.
20) O’Keeffe LM, Kearney PM, McCarthy FP, et al. Prevalence and predictors of alcohol use during pregnancy: findings from international multicentre cohort studies. BMJ Open. 2015;5(7):e006323. doi: 10.1136/bmjopen-2014-006323.
21) Rossen F, Newcombe D, Parag V, et al. Alcohol consumption in New Zealand women before and during pregnancy: findings from the growing up in New Zealand study. N Z Med J. 2018;131(1479):24-34.
22) Poole N, Wolfson L, Huber E. Health Promotion and Support Grounded in Interconnected Influences on Alcohol Use in Pregnancy. Int J Environ Res Public Health. 2025;22(8):1309. doi: 10.3390/ijerph22081309.
23) Lyall V, Wolfson L, Reid N, et al. “The Problem Is That We Hear a Bit of Everything…”: A Qualitative Systematic Review of Factors Associated with Alcohol Use, Reduction, and Abstinence in Pregnancy. Int J Environ Res Public Health. 2021;18(7):3445. doi: 10.3390/ijerph18073445.
24) Connor J, Casswell S. Alcohol-related harm to others in New Zealand: evidence of the burden and gaps in knowledge. N Z Med J. 2012;125(1360):11-27.
25) Chambers T, Mizdrak A, Herbert S, et al. The estimated health impact of alcohol interventions in New Zealand: A modelling study. Addiction. 2024;119(1):125-136. doi: 10.1111/add.16331.
26) Darrah T, Herbert S, Chambers T. A thematic analysis of alcohol and alcohol-related harm across health and social policy in Aotearoa New Zealand. Aust N Z J Public Health. 2024;48(2):100143. doi: 10.1016/j.anzjph.2024.100143.
27) Darrah T, Waa A, Jones A, Mizdrak A. Māori perspectives on alcohol. Int J Crit Indig Stud. 2021;14(1):51-64. doi: 10.5204/ijcis.v14i1.1809.
28) Mäkelä P, Montonen M. Low-risk drinking guidelines to reduce alcohol-related harm: Delphi survey to explore aspects ‘beyond epidemiology’. Addict Res Theory. 2018;26(6):487-497. doi: 10.1080/16066359.2018.1434155.
29) Department of Health. UK Chief Medical Officers’ Low Risk Drinking Guidelines [Internet]. London: Department of Health; 2016 [cited 2025 Oct 20]. Available from: https://assets.publishing.service.gov.uk/media/5a80b7ed40f0b623026951db/UK_CMOs__report.pdf
30) National Health and Medical Research Council. Australian Guidelines to Reduce Health Risks from Drinking Alcohol [Internet]. Canberra: National Health and Medical Research Council; 2020 [cited 2025 Oct 21]. Available from: https://www.nhmrc.gov.au/sites/default/files/2022-07/Australian-guidelines-to-reduce-health-risks-from-drinking-alcohol.pdf
31) Paradis C, Butt P, Shield K, et al. Canada’s Guidance on Alcohol and Health: Final Report. Ottawa: Canadian Centre on Substance Use and Addiction; 2023 [cited 2025 Oct 21]. Available from: https://www.ccsa.ca/sites/default/files/2023-01/CCSA_Canadas_Guidance_on_Alcohol_and_Health_Final_Report_en.pdf
32) Burton R, Sheron N. No level of alcohol consumption improves health. Lancet. 2018;392(10152):987-988. doi: 10.1016/S0140-6736(18)31571-X.
33) Kilian C, Lemp JM, Llamosas-Falcón L, et al. Reducing alcohol use through alcohol control policies in the general population and population subgroups: a systematic review and meta-analysis. EClinicalMedicine. 2023;59:101996. doi: 10.1016/j.eclinm.2023.101996.
34) Holmes J, Angus C, Meier PS, et al. How should we set consumption thresholds for low risk drinking guidelines? Achieving objectivity and transparency using evidence, expert judgement and pragmatism. Addiction. 2019;114(4):590-600. doi: 10.1111/add.14381.
35) Naimi TS. A fresh approach to the development of national alcohol guidelines. Addiction. 2019;114(4):601-602. doi: 10.1111/add.14428.
36) Amohia te Waiora. Standard drinks and legal limits [Internet]. Health New Zealand – Te Whatu Ora. [cited 2026 Jan 19]. Available from: https://www.alcohol.org.nz/help-and-support/advice/standard-drinks-and-legal-limits
37) GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185-235. doi: 10.1016/S0140-6736(22)00847-9. Erratum in: Lancet. 2022 Jul 30;400(10349):358. doi: 10.1016/S0140-6736(22)01389-7.
38) Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112(3):580-593. doi: 10.1038/bjc.2014.579.
39) Lyons AC, Goodwin I, Carah N, et al. Limbic platform capitalism: understanding the contemporary marketing of health-demoting products on social media. Addict Res Theory. 2023;31(3):178-183. doi: 10.1080/16066359.2022.2124976.
40) Sargent JD, Babor TF. The Relationship Between Exposure to Alcohol Marketing and Underage Drinking is Causal. J Stud Alcohol Drugs Suppl. 2020;(19):113-124. doi: 10.15288/jsads.2020.s19.113.
41) McCreanor T, Moewaka Barnes A, Goodwin I, et al. Alcohol marketing on social media: young people’s exposure, engagement and alcohol-related behaviors. Addict Res Theory. 2025;33(3):161-171. doi: 10.1080/16066359.2024.2373145.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz